0 XP   0   0   0

Verve Therapeutics Inc
Buy, Hold or Sell?

I guess you are interested in Verve Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Verve Therapeutics Inc

Let's start. I'm going to help you getting a better view of Verve Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Verve Therapeutics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Verve Therapeutics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Verve Therapeutics Inc. The closing price on 2022-09-30 was $34.35 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Verve Therapeutics Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Verve Therapeutics Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Verve Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Verve Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Verve Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--241.1%+241.1%
TTM--275.9%+275.9%
YOY--342.1%+342.1%
5Y--475.7%+475.7%
10Y--561.7%+561.7%
1.1.2. Return on Assets

Shows how efficient Verve Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Verve Therapeutics Inc to the Biotechnology industry mean.
  • -8.7% Return on Assets means that Verve Therapeutics Inc generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Verve Therapeutics Inc:

  • The MRQ is -12.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.6%TTM-8.7%-3.9%
TTM-8.7%YOY-16.9%+8.2%
TTM-8.7%5Y-12.3%+3.5%
5Y-12.3%10Y-12.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.6%-9.7%-2.9%
TTM-8.7%-8.7%0.0%
YOY-16.9%-9.2%-7.7%
5Y-12.3%-11.5%-0.8%
10Y-12.3%-12.4%+0.1%
1.1.3. Return on Equity

Shows how efficient Verve Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Verve Therapeutics Inc to the Biotechnology industry mean.
  • -13.8% Return on Equity means the company generated $-0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Verve Therapeutics Inc:

  • The MRQ is -13.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM-9.4%-4.4%
TTM-9.4%YOY-4.4%-5.0%
TTM-9.4%5Y-7.2%-2.2%
5Y-7.2%10Y-7.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.8%-11.8%-2.0%
TTM-9.4%-11.0%+1.6%
YOY-4.4%-10.6%+6.2%
5Y-7.2%-13.5%+6.3%
10Y-7.2%-14.5%+7.3%

1.2. Operating Efficiency of Verve Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Verve Therapeutics Inc is operating .

  • Measures how much profit Verve Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Verve Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Verve Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM--269.6%+269.6%
YOY--309.3%+309.3%
5Y--466.7%+466.7%
10Y--572.5%+572.5%
1.2.2. Operating Ratio

Measures how efficient Verve Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are $0.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Verve Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM-3.542-3.542
YOY-3.491-3.491
5Y-5.744-5.744
10Y-7.007-7.007

1.3. Liquidity of Verve Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Verve Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1,155.4% means the company has $11.55 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Verve Therapeutics Inc:

  • The MRQ is 11.554. The company is very able to pay all its short-term debts. +2
  • The TTM is 17.479. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.554TTM17.479-5.924
TTM17.479YOY27.113-9.634
TTM17.4795Y21.608-4.129
5Y21.60810Y21.6080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.5545.266+6.288
TTM17.4796.060+11.419
YOY27.1136.365+20.748
5Y21.6086.692+14.916
10Y21.6086.457+15.151
1.3.2. Quick Ratio

Measures if Verve Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 1,989.5% means the company can pay off $19.90 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Verve Therapeutics Inc:

  • The MRQ is 19.895. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 29.614. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ19.895TTM29.614-9.719
TTM29.614YOY30.091-0.477
TTM29.6145Y29.819-0.204
5Y29.81910Y29.8190.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.8953.985+15.910
TTM29.6144.865+24.749
YOY30.0915.192+24.899
5Y29.8195.275+24.544
10Y29.8194.997+24.822

1.4. Solvency of Verve Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Verve Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.09 means that Verve Therapeutics Inc assets are financed with 8.6% credit (debt) and the remaining percentage (100% - 8.6%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Verve Therapeutics Inc:

  • The MRQ is 0.086. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.068. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.086TTM0.068+0.019
TTM0.068YOY1.116-1.048
TTM0.0685Y0.517-0.449
5Y0.51710Y0.5170.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0860.271-0.185
TTM0.0680.269-0.201
YOY1.1160.296+0.820
5Y0.5170.361+0.156
10Y0.5170.399+0.118
1.4.2. Debt to Equity Ratio

Measures if Verve Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 9.4% means that company has $0.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Verve Therapeutics Inc:

  • The MRQ is 0.094. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.073. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.073+0.022
TTM0.073YOY0.017+0.055
TTM0.0735Y0.049+0.024
5Y0.04910Y0.0490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0940.310-0.216
TTM0.0730.311-0.238
YOY0.0170.310-0.293
5Y0.0490.382-0.333
10Y0.0490.438-0.389

2. Market Valuation of Verve Therapeutics Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Verve Therapeutics Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -5.90 means the investor is paying $-5.90 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Verve Therapeutics Inc:

  • The EOD is -13.269. Company is losing money. -2
  • The MRQ is -5.902. Company is losing money. -2
  • The TTM is -4.205. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-13.269MRQ-5.902-7.366
MRQ-5.902TTM-4.205-1.697
TTM-4.205YOY--4.205
TTM-4.2055Y-2.403-1.802
5Y-2.40310Y-2.4030.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.269-2.150-11.119
MRQ-5.902-2.332-3.570
TTM-4.205-3.889-0.316
YOY--5.087+5.087
5Y-2.403-3.697+1.294
10Y-2.403-3.390+0.987

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Verve Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.51 means the investor is paying $2.51 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Verve Therapeutics Inc:

  • The EOD is 5.642. Seems overpriced? -1
  • The MRQ is 2.510. Good. +1
  • The TTM is 4.167. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD5.642MRQ2.510+3.132
MRQ2.510TTM4.167-1.658
TTM4.167YOY0.394+3.774
TTM4.1675Y2.550+1.617
5Y2.55010Y2.5500.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.6421.816+3.826
MRQ2.5101.961+0.549
TTM4.1672.789+1.378
YOY0.3943.538-3.144
5Y2.5502.782-0.232
10Y2.5502.419+0.131

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Verve Therapeutics Inc.

3.1. Institutions holding Verve Therapeutics Inc

Institutions are holding 62.91% of the shares of Verve Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31FMR Inc8.55950.009351159101144272.2879
2022-06-30Casdin Capital, LLC5.25054.0543313816700
2022-03-31State Street Corporation4.45570.003266310689974251.0242
2022-03-31ARCH VENTURE CORP4.19758.1816250880900
2022-03-31Wellington Management Company LLP3.92520.00922346047-1593461-40.4482
2022-03-31Vanguard Group Inc3.87960.0013231877595455469.9706
2022-06-30ARK Investment Management LLC3.40330.1824203412434717920.5803
2022-03-31Redmile Group, LLC3.07071.307418353281267927.4211
2022-06-30Baker Bros Advisors LP2.370.1228141653000
2022-03-31JPMorgan Chase & Co1.87190.0031111883424153627.5318
2022-03-31Citadel Advisors Llc1.64020.004698033043312079.1506
2022-03-31Novo A/S1.25480.9028750000500007.1429
2022-03-31Federated Hermes Inc1.18830.036671023734023791.9559
2022-03-31Cormorant Asset Management, LLC1.17241.2277700710-408514-36.8288
2022-03-31HHG PLC1.15450.0076690011-472785-40.6593
2022-03-31Rock Springs Capital Management LP0.84330.2895504037-398889-44.1774
2022-06-30Geode Capital Management, LLC0.78170.0011467220409529.6071
2022-03-31Artal Group S A0.66920.382240000000
2022-03-31Partner Fund Management LP0.61870.31553697653697650
2022-03-31Adage Capital Partners Gp LLC0.59770.0155357237-10000-2.723
Total 50.904717.057530425177  

3.2. Funds holding Verve Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31ARK Genomic Revolution ETF3.73591.97492232863-20622-0.9151
2022-06-30ARK Genomic Revolution3.49621.3539208961641560224.8267
2022-07-31Vanguard Total Stock Mkt Idx Inv1.69350.002101218921380026.7789
2022-07-31Vanguard Small Cap Index1.44560.017586401317718825.7981
2022-07-29iShares Russell 2000 ETF1.35950.03738125687100.0875
2022-06-30JPMorgan Small Cap Growth A1.09580.254165495712545423.6928
2022-06-30Federated Hermes Kaufmann Small Cap A0.9790.1854585137387600196.2164
2022-06-30Federated Hermes Kaufmann Small Cap Grow0.9790.185585137387600196.2164
2022-05-31Fidelity® Small Cap Growth0.87850.1549525095-1301-0.2472
2022-07-31Vanguard Small Cap Growth Index Inv0.85140.042750885111269928.4484
2022-06-30Federated Hermes Kaufmann R0.83660.150950000000
2022-06-30Federated Hermes Kaufmann Growth0.83660.150350000000
2022-06-30Fidelity® Blue Chip Growth0.7740.0194462597-22532-4.6445
2022-07-31JPM Global Healthcare C (acc) USD0.75090.24014488314488310
2022-06-30Fidelity Advisor® Biotechnology I0.70790.40442310000
2022-06-30Fidelity Growth Compy Commingled Pl 30.64350.01223846008660.2257
2022-06-30Fidelity® Select Biotechnology0.62340.117237256700
2022-05-31Fidelity® Series Small Cap Opps0.62260.110337210000
2022-06-30Fidelity® Growth Company0.52650.0117314677-1879-0.5936
2022-07-29iShares Russell 2000 Value ETF0.51980.062131069800
Total 23.35625.485913959596  

3.3. Insider Transactions

Insiders are holding 28.462% of the shares of Verve Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-10Sekar KathiresanSELL5000029.9317839
2022-07-20Andrew BellingerSELL2000034.96629
2022-07-19Sekar KathiresanSELL5000029.9317839
2022-07-13Andrew BellingerSELL1000024.96629
2022-07-12Fmr LlcSELL16300020.78570729
2022-07-01Fmr LlcSELL3877515.66773729
2022-06-29Fmr LlcSELL3440915.59791314
2022-05-12Burt A AdelmanBUY1000012.1518700
2022-03-15Burt A AdelmanBUY400021.38
2022-03-09Fmr LlcSELL397129.01
2022-02-09Fmr LlcSELL1319029.46
2022-02-01Fmr LlcSELL3557429.04
2022-01-26Fmr LlcSELL14985331.23
2022-01-04Sekar KathiresanSELL187039.9
2021-12-28Sekar KathiresanSELL669339.9
2021-12-22Andrew BellingerSELL1500038.7
2021-12-22Sekar KathiresanSELL5700038.71
2021-12-02Andrew D AsheBUY400032.1
2021-12-02Burt A AdelmanBUY470031.34

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Verve Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--6.0887.093-14%15.642-61%10.757-43%10.757-43%
Book Value Per Share Growth---0.735-11.229+1428%17.002-104%0.870-184%0.870-184%
Current Ratio--11.55417.479-34%27.113-57%21.608-47%21.608-47%
Debt To Asset Ratio--0.0860.068+28%1.116-92%0.517-83%0.517-83%
Debt To Equity Ratio--0.0940.073+30%0.017+443%0.049+93%0.049+93%
Dividend Per Share----0%-0%-0%-0%
Eps---0.841-0.647-23%-4.037+380%-2.100+150%-2.100+150%
Gains Per Share---0.735-11.229+1428%17.002-104%0.870-184%0.870-184%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio5.642+56%2.5104.167-40%0.394+537%2.550-2%2.550-2%
Pe Ratio-13.269-125%-5.902-4.205-29%--100%-2.403-59%-2.403-59%
Price Per Share34.350+56%15.28030.493-50%20.083-24%26.031-41%26.031-41%
Quick Ratio--19.89529.614-33%30.091-34%29.819-33%29.819-33%
Return On Assets---0.126-0.087-31%-0.169+34%-0.123-3%-0.123-3%
Return On Equity---0.138-0.094-32%-0.044-68%-0.072-48%-0.072-48%
 EOD+1 -2MRQTTM+5 -8YOY+5 -85Y+5 -810Y+5 -8

4.2. Fundamental Score

Let's check the fundamental score of Verve Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.269
Price to Book Ratio (EOD)Between0-15.642
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than119.895
Current Ratio (MRQ)Greater than111.554
Debt to Asset Ratio (MRQ)Less than10.086
Debt to Equity Ratio (MRQ)Less than10.094
Return on Equity (MRQ)Greater than0.15-0.138
Return on Assets (MRQ)Greater than0.05-0.126
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Verve Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.823
Ma 20Greater thanMa 5036.684
Ma 50Greater thanMa 10034.184
Ma 100Greater thanMa 20025.440
OpenGreater thanClose34.270
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets324,267
Total Liabilities27,934
Total Stockholder Equity296,333
 As reported
Total Liabilities 27,934
Total Stockholder Equity+ 296,333
Total Assets = 324,267

Assets

Total Assets324,267
Total Current Assets298,644
Long-term Assets298,644
Total Current Assets
Cash And Cash Equivalents 72,889
Short-term Investments 220,672
Other Current Assets 5,083
Total Current Assets  (as reported)298,644
Total Current Assets  (calculated)298,644
+/-0
Long-term Assets
Property Plant Equipment 13,193
Other Assets 12,430
Long-term Assets  (as reported)25,623
Long-term Assets  (calculated)25,623
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities25,847
Long-term Liabilities2,087
Total Stockholder Equity296,333
Total Current Liabilities
Short-term Debt 907
Accounts payable 6,320
Other Current Liabilities 18,620
Total Current Liabilities  (as reported)25,847
Total Current Liabilities  (calculated)25,847
+/-0
Long-term Liabilities
Other Liabilities 2,087
Long-term Liabilities  (as reported)2,087
Long-term Liabilities  (calculated)2,087
+/-0
Total Stockholder Equity
Common Stock49
Retained Earnings -257,962
Accumulated Other Comprehensive Income -938
Capital Surplus 555,184
Total Stockholder Equity (as reported)296,333
Total Stockholder Equity (calculated)296,333
+/-0
Other
Capital Stock49
Cash and Short Term Investments 293,561
Common Stock Shares Outstanding 48,675
Common Stock Total Equity49
Liabilities and Stockholders Equity 324,267
Net Debt -71,982
Net Invested Capital 296,333
Net Tangible Assets 296,333
Net Working Capital 272,797
Short Long Term Debt Total 907



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
78,413
158,169
426,518
410,877
384,124
349,241
324,267
324,267349,241384,124410,877426,518158,16978,413000
   > Total Current Assets 
0
0
0
73,966
151,841
419,564
394,437
367,128
328,830
298,644
298,644328,830367,128394,437419,564151,84173,966000
       Cash And Cash Equivalents 
0
0
0
8,993
99,397
387,446
148,134
64,330
91,420
72,889
72,88991,42064,330148,134387,44699,3978,993000
       Short-term Investments 
0
0
0
63,119
50,126
30,178
241,076
296,112
231,879
220,672
220,672231,879296,112241,07630,17850,12663,119000
       Net Receivables 
0
0
0
0
0
0
0
2,696
0
0
002,6960000000
       Other Current Assets 
0
0
0
0
2,318
1,940
5,227
6,686
5,531
5,083
5,0835,5316,6865,2271,9402,3180000
   > Long-term Assets 
0
0
0
4,447
6,328
6,954
16,440
16,996
20,411
25,623
25,62320,41116,99616,4406,9546,3284,447000
       Property Plant Equipment 
0
0
0
0
5,202
6,417
8,909
9,063
12,472
13,193
13,19312,4729,0638,9096,4175,2020000
       Other Assets 
0
0
0
0
1,126
537
7,531
7,933
7,939
12,430
12,4307,9397,9337,5315371,1260000
> Total Liabilities 
0
0
0
142,322
234,600
21,122
25,942
26,772
17,851
27,934
27,93417,85126,77225,94221,122234,600142,322000
   > Total Current Liabilities 
0
0
0
7,315
6,684
8,649
20,251
22,024
14,803
25,847
25,84714,80322,02420,2518,6496,6847,315000
       Short-term Debt 
0
0
0
0
0
0
2,295
1,955
1,432
907
9071,4321,9552,295000000
       Accounts payable 
0
0
0
36
2,487
1,530
3,579
7,077
2,438
6,320
6,3202,4387,0773,5791,5302,48736000
       Other Current Liabilities 
0
0
0
0
4,197
7,119
14,377
12,992
10,933
18,620
18,62010,93312,99214,3777,1194,1970000
   > Long-term Liabilities 
0
0
0
135,007
227,916
12,473
5,691
4,748
3,048
2,087
2,0873,0484,7485,69112,473227,916135,007000
       Other Liabilities 
0
0
0
0
8,997
12,473
5,510
4,748
3,048
2,087
2,0873,0484,7485,51012,4738,9970000
       Deferred Long Term Liability 
0
0
0
0
663
13
0
0
0
0
0000136630000
> Total Stockholder Equity
0
0
0
-63,909
-76,431
405,396
384,935
357,352
331,390
296,333
296,333331,390357,352384,935405,396-76,431-63,909000
   Common Stock
0
0
0
0
3
48
48
49
49
49
494949484830000
   Retained Earnings Total Equity-257,962-217,016-186,850-155,513-132,76400000
   Accumulated Other Comprehensive Income 
0
0
0
0
7
3
-2
-228
-732
-938
-938-732-228-2370000
   Capital Surplus 
0
0
0
0
0
538,109
540,402
544,381
549,089
555,184
555,184549,089544,381540,402538,10900000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
0
0
3,358
538,109
540,402
544,381
549,089
555,184
555,184549,089544,381540,402538,1093,3580000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-87,067
Operating Income-87,067-87,067
 
Operating Expense (+$)
Research Development68,202
Selling General Administrative18,865
Selling And Marketing Expenses-
Operating Expense87,06787,067
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Net Interest Income1420
 
Pretax Income (+$)
Operating Income-87,067
Net Interest Income142
Other Non-Operating Income Expenses-33,247
Income Before Tax (EBT)-120,314-53,820
EBIT - interestExpense = -87,067
-120,314
-120,314
Interest Expense-
Earnings Before Interest and Taxes (ebit)-87,067-120,314
Earnings Before Interest and Taxes (ebitda)-85,532
 
After tax Income (+$)
Income Before Tax-120,314
Tax Provision--
Net Income From Continuing Ops-120,314-120,314
Net Income-120,314
Net Income Applicable To Common Shares-120,314
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses87,067
Total Other Income/Expenses Net-33,24733,105
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
20 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
20 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
20 minutes ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
24 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
26 minutes ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
26 minutes ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
29 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
31 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
31 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
31 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
33 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
33 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
35 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
35 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
36 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
42 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
44 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
44 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
45 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
46 minutes ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
46 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
48 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
48 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
49 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart